References
- Urayama A, Yamada N, Sasaki T. Unilateral acute uveitis with periarteritis and detachment. Jpn J Clin Ophthalmol. 1971;25:607–619
- Culbertson WW, Blumenkranz MS, Haines H. The acute retinal necrosis syndrome part 2. Histopathology and etiology. Ophthalmology. 1982;89:1317–1325
- Holland GN, Executive Committee of the American Uveitis Society. Standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol. 1994;117:663–667
- Abe T, Tsuchida K, Tamai M. A comparative study of the polymerase chain reaction and local antibody production in acute retinal necrosis syndrome and cytomegalovirus retinitis. Graefes Arch Clin Exp Ophthalmol. 1996;234:419–424
- Boer JH, Verhagen C, Bruinenberg M. Serologic and Polymerase Chain Reaction Analysis of Intraocular Fluids in the Diagnosis of Infectious Uveitis. Am J Ophthalmol. 1996;121:650–658
- Rothova A, de Boer JH, Ten Dam-van Loon NH, et al. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology. 2008;115:306–311
- Muthiah MN, Michaelides M, Child CS, et al. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91:1452–1455
- Cochrane TF, Silvestri G, McDowell C, et al. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye. 2012;26:370–377
- Wong RW, Jumper JM, McDonald HR, et al. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013;97:545–552
- Taylor SRJ, Hamilton R, Hooper CY, et al. Valacyclovir in the treatment of acute retinal necrosis. BMC Ophthalmol. 2012;12:1–5
- Jeon S, Kakizaki H, Lee WK, et al. Effect of prolonged oral acyclovir treatment in acute retinal necrosis. Ocul Immunol Inflamm. 2012;20:288–292
- Tran TH, Rozenberg F, Cassoux N, et al. Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthalmol. 2003;87:79–83
- Takase H, Okada AA, Goto H, et al. Development and validation of new diagnostic criteria for acute retinal necrosis. Jpn J Ophthalmol. 2015;59:14–20
- Wellington K. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs. 2005;65:859–878
- Tran TH, Bodaghi B, Rozenberg F. Prise en charge diagnostique et therapeutique des rétinites nécrosantes herpétiques. J Fr Ophtalmol. 2004;27:223–236
- Field HF. Herpes simplex virus antiviral drug resistance- current trends and future prospects. J Clin Virol. 2001;21:261–269
- Tam PMK, Hooper CY, Lightman S. Antiviral selection in the management of acute retinal necrosis. Clin Ophthalmol. 2010;4:11–20
- Flaxel CJ, Yeh S, Lauer AK. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:133–144
- Palay D, Sternberg P, Davis J. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Ophthalmology. 1991;112:250–255
- Park JJ, Pavesio C. Prophylactic laser photocoagulation for acute retinal necrosis: Does it raise more questions than answers? Br J Ophthalmol. 2008;92:1161–1162
- Hillenkamp J, Nölle B, Bruns C, et al. Acute retinal necrosis: clinical features, early vitrectomy and outcomes. Ophthalmology. 2009;116:1971–1975